Published in J Virol on March 01, 1998
Structural basis for the function and inhibition of an influenza virus proton channel. Nature (2008) 5.69
Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2009) 2.32
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production. J Virol (2006) 2.18
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol (2000) 1.96
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
Influence of solubilizing environments on membrane protein structures. Trends Biochem Sci (2010) 1.74
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Functional importance of the coiled-coil of the Ebola virus glycoprotein. J Virol (2000) 1.59
Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus. Curr Opin Struct Biol (2011) 1.56
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
Structural basis for proton conduction and inhibition by the influenza M2 protein. Protein Sci (2012) 1.36
Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy. J Am Chem Soc (2011) 1.30
The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells. J Virol (2005) 1.13
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. PLoS One (2012) 0.97
Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR. Protein Sci (2013) 0.94
Transmembrane communication: general principles and lessons from the structure and function of the M2 proton channel, K⁺ channels, and integrin receptors. Annu Rev Biochem (2011) 0.92
The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence. Virology (2010) 0.91
Flu BM2 structure and function. Nat Struct Mol Biol (2009) 0.77
Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine. Front Bioeng Biotechnol (2015) 0.76
Host cellular protein TRAPPC6AΔ interacts with influenza A virus M2 protein and regulates viral propagation by modulating M2 trafficking. J Virol (2016) 0.75
Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes. PLoS One (2016) 0.75
Viroporins, Examples of the Two-Stage Membrane Protein Folding Model. Viruses (2015) 0.75
The Influenza M2 Ectodomain Regulates the Conformational Equilibria of the Transmembrane Proton Channel: Insights from Solid-State Nuclear Magnetic Resonance. Biochemistry (2016) 0.75
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell (1991) 4.97
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins. Virology (1970) 3.58
Studies on the formation of the influenza virus envelope. Virology (1974) 3.39
Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene. Nature (1981) 3.29
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology (1992) 3.19
Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J (1990) 2.93
Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol (1992) 2.91
Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. J Virol (1993) 2.54
Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J Virol (1996) 2.30
A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J (1994) 2.09
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology (1994) 1.91
Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology (1996) 1.87
Phenotypic mixing of envelope proteins of the parainfluenza virus SV5 and vesicular stomatitis virus. J Virol (1970) 1.85
Basis for selective incorporation of glycoproteins into the influenza virus envelope. J Virol (1993) 1.84
Assembly of membrane glycoproteins studied by phenotypic mixing between mutants of vesicular stomatitis virus and retroviruses. Virology (1980) 1.82
Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol (1994) 1.75
Sequence determination of the Sendai virus fusion protein gene. J Gen Virol (1985) 1.73
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. J Virol (1995) 1.68
The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes. Virus Res (1995) 1.58
Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology (1996) 1.58
Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells. J Virol (1981) 1.52
The intracellular distribution of influenza virus matrix protein and nucleoprotein in infected cells and their relationship to haemagglutinin in the plasma membrane. J Gen Virol (1988) 1.35
Phenotypic mixing of vesicular stomatitis virus with fowl plague virus. Acta Virol (1972) 1.30
The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology (1987) 1.28
Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system. Virology (1993) 1.06
Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus. J Virol (1989) 0.98
Properties of host components of PR8 influenza virus. Intervirology (1981) 0.78
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science (2001) 18.43
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol (1999) 7.89
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (1994) 5.49
Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol (1999) 5.21
Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44
Genetic reassortment between avian and human influenza A viruses in Italian pigs. Virology (1993) 4.40
Potential for transmission of avian influenza viruses to pigs. J Gen Virol (1994) 4.24
Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? Virology (1984) 4.15
Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol (2000) 4.10
Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis (1996) 4.04
Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol (1991) 4.01
Origin of the pandemic 1957 H2 influenza A virus and the persistence of its possible progenitors in the avian reservoir. Virology (1993) 3.54
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Biologic importance of neuraminidase stalk length in influenza A virus. J Virol (1993) 3.51
Ebola virus VP40-induced particle formation and association with the lipid bilayer. J Virol (2001) 3.41
Evolution of influenza A virus PB2 genes: implications for evolution of the ribonucleoprotein complex and origin of human influenza A virus. J Virol (1990) 3.40
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol (1994) 3.31
Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. J Virol (1991) 3.29
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology (1997) 3.10
Sialic acid species as a determinant of the host range of influenza A viruses. J Virol (2000) 3.10
Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J Virol (1998) 3.07
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol (1997) 3.00
Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology (1995) 2.99
A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A (1998) 2.86
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Nuclear import and export of influenza virus nucleoprotein. J Virol (1997) 2.69
Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J (2000) 2.54
Emergence of avian H1N1 influenza viruses in pigs in China. J Virol (1996) 2.44
Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41
Evolution of the nucleoprotein gene of influenza A virus. J Virol (1990) 2.40
Perpetuation of influenza A viruses in Alaskan waterfowl reservoirs. Arch Virol (1995) 2.38
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol (1997) 2.38
Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J Virol (1992) 2.37
Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology (2000) 2.33
Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain. Virology (1987) 2.30
The Sendai virus nucleocapsid exists in at least four different helical states. J Virol (1989) 2.30
Properties of incomplete Sendai virions and subgenomic viral RNAs. Virology (1970) 2.26
"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology (2000) 2.22
Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology (1994) 2.21
Wild ducks are the reservoir for only a limited number of influenza A subtypes. Epidemiol Infect (1993) 2.21
Plasmid-driven formation of influenza virus-like particles. J Virol (2000) 2.18
Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation. J Virol (1993) 2.15
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol (2001) 2.13
Similar frequencies of antigenic variants in Sendai, vesicular stomatitis, and influenza A viruses. Virology (1980) 2.11
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09
Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol (2004) 2.04
Influenza viral infection of swine in the United States 1988-1989. Arch Virol (1991) 2.02
Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy. Virology (1997) 1.98
Sendai virus replication: an ultrastructural comparison of productive and abortive infections in avian cells. J Gen Virol (1970) 1.98
Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J Virol (1994) 1.93
Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology (1994) 1.91
Characterization of a new avian-like influenza A virus from horses in China. Virology (1992) 1.90
Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet Microbiol (2000) 1.86
The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J Immunol (2001) 1.85
Ribonucleic acid transcriptases in Sendai Virions and infected cells. J Virol (1971) 1.84
Evolution of the hemagglutinin of equine H3 influenza viruses. Virology (1989) 1.83
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A (1999) 1.78
Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol (1999) 1.78
Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses. Virus Res (1998) 1.78
Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J Virol (2001) 1.77
Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology (1995) 1.75
Evolutionary pathways of the PA genes of influenza A viruses. Virology (1989) 1.70
Reverse genetics system for generation of an influenza A virus mutant containing a deletion of the carboxyl-terminal residue of M2 protein. J Virol (1995) 1.68
Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol (2001) 1.67
Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol (1988) 1.67
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66
Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol (2000) 1.63
Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol (2001) 1.63
Coinfection of wild ducks by influenza A viruses: distribution patterns and biological significance. J Virol (1997) 1.60
Functional importance of the coiled-coil of the Ebola virus glycoprotein. J Virol (2000) 1.59
Antigenic and molecular characterization of subtype H13 hemagglutinin of influenza virus. Virology (1989) 1.59
Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58
DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J Virol (1999) 1.57
Application of Directigen FLU-A for the detection of influenza A virus in human and nonhuman specimens. J Clin Microbiol (1992) 1.54
Host-range barrier of influenza A viruses. Vet Microbiol (2000) 1.54
Infectivity-enhancing antibodies to Ebola virus glycoprotein. J Virol (2001) 1.52
Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology (1987) 1.52
Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus. J Virol (1994) 1.52